Adalimumab every other week vs placebo
Frequency of serious adverse effects · participants with hidradenitis suppurativa
Adalimumab every other week showed no clear difference in frequency of serious adverse effects compared with placebo (high certainty).
1 finding from 1 review
- RR 1.47 [0.26, 8.44]2 studies · 124 participantsHigh